Catalyst Wire Dossier Catalyst Wire Dossier

LZM012

· Livzon Pharmaceutical Group Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LZM012, covering 2023-11-01 to 2023-11-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of LZM012 [Phase 3]

See pricing